Trailing-twelve-month (TTM) revenue is $214.46 Million with a year-over-year growth of (2.17%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $52,170,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-14 |
| Q4 FY2025Period ended 2025-12-31 | $50,272,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-31 |
| Q1 FY2026Period ended 2026-03-31 | $45,124,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-15 |
| Q2 FY2026Period ended 2026-06-30 | $66,896,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-14 |
| TTM revenue | $214,462,000 |
Current P/S: $64,003,836 market capitalization ÷ $214,462,000 TTM revenue = 0.30x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $66.90M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T22:52:32.523Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2014-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Cinema | $67M | $127M | $191M | $208M | $195M | $189M |
| Real Estate Revenue | $11M | $12M | $12M | $15M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20122012-12-31 · USD | FY20132013-12-31 · USD | FY20142014-12-31 · USD |
|---|---|---|---|
| N | $25M | $26M | $27M |
| U | $122M | $132M | $131M |
$214.46M
$214.46 Million
(2.17%)
vs. $219.22M a year ago (TTM)
+21.04%
5 Year compound annual growth rate
1 Year
(2.17%)
3 Year
(1.67%)
5 Year
+21.04%
10 Year
(1.74%)
15 Year
(0.63%)
20 Year
+3.66%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $202.99M | ($7.54M) | (3.58%) |
| 2024 | $210.53M | ($12.22M) | (5.48%) |
| 2023 | $222.74M | +$19.63M | +9.66% |
| 2022 | $203.12M | +$64.06M | +46.06% |
| 2021 | $139.06M | +$61.20M | +78.60% |
| 2020 |
TTM Growth
(2.17%)
3-Year CAGR
(1.67%)
5-Year CAGR
+21.04%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T22:52:32.523Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $15M |
| $14M |
| $77.86M |
| ($198.91M) |
| (71.87%) |
| 2019 | $276.77M | ($32.62M) | (10.54%) |
| 2018 | $309.38M | +$29.65M | +10.60% |
| 2017 | $279.73M | +$9.26M | +3.42% |
| 2016 | $270.47M | +$13.15M | +5.11% |
